Unfortunately, Glomerular Disease Study and Trial Consortium has limited available public data.
Create an account for free to request more data.
Mission
The primary purposes of the corporation shall be to raise awareness about, promote diagnosis and treatment of, and help patients with kidney diseases.
Basic Information
Tax-Exempt
Founded in
2021
EIN
86-2088226
Total Assets
$264.1 thousand
UN Sustainable Development Goals Supported
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Showing 1 of 1 goals
MIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
51
58
/100
Program Expense Ratio
86.69%
18
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.03301
20
/20
Working Capital Ratio
2.766
16
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 153.5K | 47.92% |
| Program Services | 165.4K | 51.61% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 1.5K | 0.47% |
| Total Revenue | 320.4K | 100.00% |
Related Nonprofits
Glomerular Disease Study and Trial Consortium
Med Research
Hereditary Disease ResearchDyrk1a Syndrome US
Med Research
Hereditary Disease ResearchAdld Center
Med Research
Hereditary Disease ResearchThe Kat6a Foundation Inc.
Med Research
Hereditary Disease ResearchPediatric Research and Advocacy Initiative
Med Research
Hereditary Disease Research